Session Organizer: Mary MacCarthy, University of Minnesota
This session will review three applications of artificial intelligence in medical devices: fetal and maternal health, early screening and care of osteoporosis patients, and early detection of Alzheimer's and other neurological diseases. Then the panel will discuss AI strategy and development, risk mitigation and resources for learning more about AI. Panelists include:
Chris Taylor, Osteoapp.ai
Chris Taylor
CEO, OsteoApp.ai
Chris Taylor, CEO of OsteoApp is a 15+ year leader in the medical industry spanning medical device, managed care with special interest in healthcare finance, digital health, and advanced care delivery models. Chris focuses his time supporting early-stage healthcare startups as an Angel Investor, fractional C-suite executive, and advisor. He has helped startups establish sustainable multi-year growth trajectories and capitalization to rapidly increase enterprise value.
Alon Hazan, RetiSpec
Alon Hazan
Head of Artificial Intelligence & R&D
Alon holds a BSc in Physics and Optics from the Technion and has worked for 7 years on anti-missile optical defense systems. He then proceeded to an MSc in Electrical Engineering and Machine Learning, where he focused on neural networks and the human visual system. Over the past decade he has worked in the field of medical imaging AI. At IBM research he developed an AI for Breast Cancer detection in Ultrasound and Mammography. After relocating to Toronto he joined a medical startup for Prostate Cancer in MRI and designed and submitted two AI models that were cleared as medical devices by the FDA. Currently Alon serves as the Head of AI R&D at RetiSpec, where he is developing a medical device to detect Alzheimer’s using noninvasive hyperspectral retinal imaging and AI.
Ben Teplitzky, Marani Health
Ben Teplitzky, PhD
VP, AI and Data Science, Marani Health
Ben brings 15 years of biomedical engineering and data science experience to the field of medical technology. He has a proven history of leveraging the latest advancements in AI/ML/DL to develop modern scalable solutions for historically underserved areas of medicine. Prior to Boston Scientific’s acquisition of Preventice Solutions in 2021, Ben created BeatLogic®, the company’s artificial intelligence platform for automated ECG interpretation. Ben is well-versed in designing, building, and validating data pipelines, analysis platforms, and advanced algorithms. Ben received his Bachelor of Science in Biomedical Engineering from Arizona State University and Ph.D in Biomedical Engineering from the University of Minnesota.
Session Organizer
Mary MacCarthy, MBA
Venture Center Senior Program Manager
Discovery Capital Manager
Technology Commercialization Venture Center
University of Minnesota
Mary E. MacCarthy MBA is a Senior Program Manager in the University of Minnesota Venture Center where she works with university innovators to launch startups, manages the university’s seed investment program Discovery Capital and the 470 member volunteer group. Previously she worked at Medtronic, 3M, Imation, Cardiovascular Systems Inc and launched two startups. Mary serves on the Board of Directors of Anatomic Inc, MNSBIR Inc, RoundtableRx and the advisory board for the Center for Economic Inclusion’s Project Vanguard.